Thedefinition, present epidemiology and etiopathology of MDR-TB and the therapeuticprinciple, drugselection and newchemotherapeutic agents for the treatment of MDR-TB were discussed.
Dr Klaus Kurtenbach, of the Wellcome Trust Centre for the Epidemiology of Infectious Disease at Oxford University, told BBC News Online that the new technique sounded "good in principle".